| 1 |
Ikeda T, Yanaga K, Kishikawa K, et al. Ischemic injury in liver transplantation: difference in injury sites between warm and cold ischemia in rats[J]. Hepatology, 1992, 16(2):454-461.
|
| 2 |
Zhai Y, Busuttil RW, Kupiec-Weglinski JW. Liver ischemia and reperfusion injury: new insights into mechanisms of innate-adaptive immune-mediated tissue inflammation[J]. Am J Transplant, 2011, 11(8): 1563-1569.
|
| 3 |
Zhai Y, Petrowsky H, Hong JC, et al. Ischaemia-reperfusion injury in liver transplantation-from bench to bedside[J]. Nat Rev Gastroenterol Hepatol, 2013, 10(2): 79-89.
|
| 4 |
Lentsch AB, Kato A, Yoshidome H, et al. Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury[J]. Hepatology, 2000, 32(2):169-173.
|
| 5 |
Tsung A, Klune JR, Zhang X, et al. HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling[J]. J Exp Med, 2007, 204(12):2913-2923.
|
| 6 |
Jaeschke H. Mechanisms of reperfusion injury after warm ischemia of the liver[J]. J Hepatobiliary Pancreat Surg, 1998, 5(4):402-408.
|
| 7 |
Bahde R, Spiegel HU. Hepatic ischaemia-reperfusion injury from bench to bedside[J]. Br J Surg, 2010, 97(10):1461-1475.
|
| 8 |
Jaeschke H. Reactive oxygen and mechanisms of inflammatory liver injury: Present concepts[J]. J Gastroenterol Hepatol, 2011, 26(Suppl 1):173-179.
|
| 9 |
Hide D, Ortega-Ribera M, Garcia-Pagan JC, et al. Effects of warm ischemia and reperfusion on the liver microcirculatory phenotype of rats: underlying mechanisms and pharmacological therapy[J]. Sci Rep, 2016, 6:22107.
|
| 10 |
Csak T, Velayudham A, Hritz I, et al. Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice[J]. Am J Physiol Gastrointest Liver Physiol, 2011, 300(3):G433-G441.
|
| 11 |
Nayak L, Lin Z, Jain MK. "Go with the flow" ：how Kruppel-like factor 2 regulates the vasoprotective effects of shear stress[J]. Antioxid Redox Signal, 2011, 15(5):1449-1461.
|
| 12 |
Gracia-Sancho J, Villarreal G Jr, Zhang Y, et al. Flow cessation triggers endothelial dysfunction during organ cold storage conditions: strategies for pharmacologic intervention[J]. Transplantation, 2010, 90(2):142-149.
|
| 13 |
Liu Z, Zhang X, Xiao Q, et al. Pretreatment donors after circulatory death with simvastatin alleviates liver ischemia reperfusion injury through a KLF2-dependent mechanism in rat[J]. Oxid Med Cell Longev, 2017：3861914.
|
| 14 |
Klune JR, Tsung A. Molecular biology of liver ischemia/reperfusion injury: established mechanisms and recent advancements[J]. Surg Clin North Am, 2010, 90(4):665-677.
|
| 15 |
Tsung A, Sahai R, Tanaka H, et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion[J]. J Exp Med, 2005, 201(7):1135- 1143.
|
| 16 |
Cursio R, Colosetti P, Gugenheim J. Gugenheim, Autophagy and liver ischemia-reperfusion injury[J]. Biomed Res Int, 2015：417590.
|
| 17 |
Chouchani ET, Pell VR, James AM, et al. A unifying mechanism for mitochondrial superoxide production during ischemia-reperfusion injury[J]. Cell Metab, 2016, 23(2):254-263.
|
| 18 |
Reddy NM, Kleeberger SR, Kensler TW, et al. Correction: disruption of Nrf2 impairs the resolution of hyperoxia-induced acute lung injury and inflammation in mice[J]. J Immunol, 2017, 198(9):3755.
|
| 19 |
Huang J, Yue S, Ke B, et al. Nuclear factor erythroid 2-related factor 2 regulates toll-like receptor 4 innate responses in mouse liver ischemia-reperfusion injury through Akt-forkhead box protein O1 signaling network[J]. Transplantation, 2014, 98(7):721-728.
|
| 20 |
Sun J, Wu Q, Sun H, et al. Inhibition of histone deacetylase by butyrate protects rat liver from ischemic reperfusion injury[J]. Int J Mol Sci, 2014, 15(11):21069-21079.
|
| 21 |
Kato H, Kuriyama N, Duarte S, et al. MMP-9 deficiency shelters endothelial PECAM-1 expression and enhances regeneration of steatotic livers after ischemia and reperfusion injury[J]. J Hepatol, 2014, 60(5):1032-1039.
|
| 22 |
Zhang C, Liao Y, Li Q, et al. Recombinant adiponectin ameliorates liver ischemia reperfusion injury via activating the AMPK/eNOS pathway[J]. PLoS One, 2013, 8(6):e66382.
|
| 23 |
Massip-Salcedo M, Zaouali MA, Padrissa-Altés S, et al. Activation of peroxisome proliferator-activated receptor-alpha inhibits the injurious effects of adiponectin in rat steatotic liver undergoing ischemia-reperfusion[J]. Hepatology, 2008, 47(2):461-472.
|
| 24 |
Elias-Miró M, Massip-Salcedo M, Raila J, et al. Retinol binding protein 4 and retinol in steatotic and nonsteatotic rat livers in the setting of partial hepatectomy under ischemia/reperfusion[J]. Liver Transpl, 2012, 18(10):1198-1208.
|
| 25 |
Elias-Miró M, Mendes-Braz M, Cereijo R, et al. Resistin and visfatin in steatotic and non-steatotic livers in the setting of partial hepatectomy under ischemia-reperfusion[J]. J Hepatol, 2014, 60(1): 87-95.
|
| 26 |
Zhang XJ, Cheng X, Yan ZZ, et al. An ALOX12-12-HETE-GPR31 signaling axis is a key mediator of hepatic ischemia-reperfusion injury[J]. Nat Med, 2018, 24(1):73-83.
|
| 27 |
Shen XD, Ke B, Zhai Y, et al. Absence of toll-like receptor 4 (TLR4) signaling in the donor organ reduces ischemia and reperfusion injury in a murine liver transplantation model[J]. Liver Transpl, 2007, 13(10):1435-1443.
|
| 28 |
Erridge C. Endogenous ligands of TLR2 and TLR4: agonists or assistants？[J]. J Leukoc Biol, 2010, 87(6):989-999.
|
| 29 |
Tsung A, Klune JR, Zhang X, et al. HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling[J]. J Exp Med, 2007, 204(12):2913-2923.
|
| 30 |
Dhupar R, Klune JR, Evankovich J, et al. Interferon regulatory factor 1 mediates acetylation and release of high mobility group box 1 from hepatocytes during murine liver ischemia-reperfusion injury[J]. Shock, 2011, 35(3):293-301.
|
| 31 |
Schiraldi M, Raucci A, Muñoz LM, et al. HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4[J]. J Exp Med, 2012, 209(3):551-563.
|
| 32 |
McDonald B, Pittman K, Menezes GB, et al. Intravascular danger signals guide neutrophils to sites of sterile inflammation[J]. Science, 2010, 330(6002):362-366.
|
| 33 |
Zhu P, Duan L, Chen J, et al. Gene silencing of NALP3 protects against liver ischemia-reperfusion injury in mice[J]. Hum Gene Ther, 2011, 22(7):853-864.
|
| 34 |
Cursio R, Colosetti P, Gugenheim J. Autophagy and liver ischemia-reperfusion injury[J]. Biomed Res Int, 2015：417590.
|
| 35 |
Gracia-Sancho J, Guixé-Muntet S, Hide D, et al. Modulation of autophagy for the treatment of liver diseases[J]. Expert Opin Investig Drugs, 2014, 23(7):965-977.
|
| 36 |
Minor T, Stegemann J, Hirner A, et al. Impaired autophagic clearance after cold preservation of fatty livers correlates with tissue necrosis upon reperfusion and is reversed by hypothermic reconditioning[J]. Liver Transpl, 2009, 15(7):798-805.
|
| 37 |
Guixé-Muntet S, de Mesquita FC, Vila S, et al. Cross-talk between autophagy and KLF2 determines endothelial cell phenotype and microvascular function in acute liver injury[J]. J Hepatol, 2017, 66(1):86-94.
|
| 38 |
Farid WR, Pan Q, van der Meer AJ, et al. Hepatocyte-derived microRNAs as serum biomarkers of hepatic injury and rejection after liver transplantation[J]. Liver Transpl, 2012, 18(3):290-297.
|
| 39 |
Kim KH, Dhupar R, Ueki S, et al. Donor graft interferon regulatory factor-1 gene transfer worsens liver transplant ischemia/reperfusion injury[J]. Surgery, 2009, 146(2):181-189.
|
| 40 |
Yokota S, Yoshida O, Dou L, et al. IRF-1 promotes liver transplant ischemia/reperfusion injury via hepatocyte IL-15/IL-15Ralpha production[J]. J Immunol, 2015, 194(12):6045-6056.
|
| 41 |
Ueki S, Castellaneta A, Yoshida O, et al. Hepatic B7 homolog 1 expression is essential for controlling cold ischemia/reperfusion injury after mouse liver transplantation[J]. Hepatology, 2011, 54(1):216-228.
|